+Compare
MDVL
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
9.67M

MDVL MedAvail Holdings Forecast, Technical & Fundamental Analysis

a developer of therapeutic products, nutritional supplements and other technologies

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for MDVL with price predictions
08:00 PM EDT Aug 30, 2023

MDVL in -5.08% downward trend, falling for three consecutive days on August 31, 2023

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MDVL declined for three days, in of 346 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for MDVL entered a downward trend on August 31, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where MDVL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MDVL advanced for three days, in of 173 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.419) is normal, around the industry mean (10.538). P/E Ratio (0.000) is within average values for comparable stocks, (143.802). MDVL's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (5.568). MDVL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.037). P/S Ratio (0.229) is also within normal values, averaging (0.953).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MDVL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDVL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Walgreens Boots Alliance (NASDAQ:WBA), Rite Aid Corp (NYSE:RAD).

Industry description

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

Market Cap

The average market capitalization across the Drugstore Chains Industry is 2.91B. The market cap for tickers in the group ranges from 3.29K to 18.52B. WBA holds the highest valuation in this group at 18.52B. The lowest valued company is RLLVF at 3.29K.

High and low price notable news

The average weekly price growth across all stocks in the Drugstore Chains Industry was -5%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 3%. HITI experienced the highest price growth at 17%, while LFLY experienced the biggest fall at -39%.

Volume

The average weekly volume growth across all stocks in the Drugstore Chains Industry was -57%. For the same stocks of the Industry, the average monthly volume growth was 26% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 73
Price Growth Rating: 64
SMR Rating: 76
Profit Risk Rating: 92
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

MDVL is expected to report earnings to fall 81.25% to -2 cents per share on August 10

MedAvail Holdings MDVL Stock Earnings Reports
Q2'23
Est.
$-0.03
Q1'23
Beat
by $0.05
Q4'22
Est.
$-0.14
Q3'22
Est.
$-0.15
Q2'22
Beat
by $0.09
The last earnings report on May 18 showed earnings per share of -15 cents, beating the estimate of -20 cents. With 376.00 shares outstanding, the current market capitalization sits at 9.67M.
A.I. Advisor
published General Information

General Information

a developer of therapeutic products, nutritional supplements and other technologies

Industry DrugstoreChains

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
4720 East Cotton Gin Loop
Phone
+1 905 812-0023
Employees
279
Web
https://www.medavail.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGC0.840.07
+9.48%
Canopy Growth Corp
RVTY109.501.01
+0.93%
Revvity
HIHO2.150.01
+0.47%
Highway Holdings Limited
PRTK2.23N/A
N/A
Paratek Pharmaceuticals
SLG36.89-0.55
-1.47%
SL Green Realty Corp

MDVL and

Correlation & Price change

A.I.dvisor tells us that MDVL and WBA have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDVL and WBA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDVL
1D Price
Change %
MDVL100%
+4.34%
WBA - MDVL
24%
Poorly correlated
-1.54%
LFMD - MDVL
19%
Poorly correlated
N/A
HITI - MDVL
18%
Poorly correlated
+5.88%
RAD - MDVL
14%
Poorly correlated
-6.54%
LFLY - MDVL
13%
Poorly correlated
-11.04%
More

Groups containing MDVL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDVL
1D Price
Change %
MDVL100%
+4.34%
nutrition
(undefined stocks)
50%
Loosely correlated
+0.87%
Drugstore Chains
(undefined stocks)
44%
Loosely correlated
-0.10%
pharmaceuticals
(undefined stocks)
25%
Poorly correlated
-0.53%
Retail Trade
(undefined stocks)
23%
Poorly correlated
-0.13%
therapeutics
(undefined stocks)
19%
Poorly correlated
-1.01%